JAMTEKI
JAMTEKI
Approved
DIN Number
02543036
Drug Class
Human
Market Date
Mar 1, 2024
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543036
AIG Number0152506001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC05 USTEKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
USTEKINUMABActive
Strength: 45 MG / 0.5 ML
Monograph: USTEKINUMAB